CUBIST PHARMACEUTICALS INC 4
4 · CUBIST PHARMACEUTICALS INC · Filed Sep 10, 2013
Insider Transaction Report
Form 4
Rosenberg Martin
Director
Transactions
- Exercise/Conversion
Common Stock
2013-09-09$38.06/sh+9,472$360,504→ 21,477 total - Sale
Common Stock
2013-09-09$65.00/sh−15,472$1,005,680→ 6,005 total - Exercise/Conversion
Stock Options (Right to Buy)
2013-09-09−6,000→ 0 totalExercise: $9.56From: 2006-06-08Exp: 2015-06-08→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2013-09-09$9.56/sh+6,000$57,360→ 12,005 total - Exercise/Conversion
Stock Options (Right to Buy)
2013-09-09−9,472→ 0 totalExercise: $38.06From: 2012-06-02Exp: 2021-06-02→ Common Stock (9,472 underlying)
Footnotes (3)
- [F1]Sold pursuant to a Rule 10(b)5-1 Plan
- [F2]Option vests 100% on one-year anniversary of grant.
- [F3]Options vest 100% on the earlier of the first anniversary of the grant date or the date of the Company's 2012 Annual Meeting of Stockholders.